IMMUNOTHERAPY FOR MELANOMA
Melanoma is one of the most dangerous forms of skin cancer. Aggressive growth with a high risk of distant metastasis is the cause of the high death rate from skin melanoma worldwide. Melanoma that has metastasized beyond the lymph nodes requires more aggressive treatment. The standard treatment moda...
Saved in:
| Main Authors: | E. A. Borobova, A. A. Zheravin |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Russian Academy of Sciences, Tomsk National Research Medical Center
2017-09-01
|
| Series: | Сибирский онкологический журнал |
| Subjects: | |
| Online Access: | https://www.siboncoj.ru/jour/article/view/571 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nanoliposome-encapsulated MAGE peptides: A promising melanoma vaccine to activate human dendritic cells
by: Azin Bavafa, et al.
Published: (2025-05-01) -
Current state and prospects of using dendritic cell vaccination for cancer immunotherapy
by: I.Yu. Filin, et al.
Published: (2022-09-01) -
Theory and Practice of Immunotherapy Directed against the PRAME Antigen
by: VA Misyurin
Published: (2018-04-01) -
Tumor lysate particle only vaccine (TLPO) vs. Tumor lysate particle-loaded, dendritic cell vaccine (TLPLDC) to prevent recurrence in resected stage III/IV melanoma patients: Results of a phase I/IIa trial
by: Spencer G. Van Decar, et al.
Published: (2024-01-01) -
Progress and challenges in melanoma immunotherapy
by: LIN Jing, et al.
Published: (2025-07-01)